Emcure Pharmaceuticals Ltd

📊 Emcure Pharma FY26: Revenue up ~18% to ~₹9,322 Cr, margin expands, Gennova fully acquired

- Revenue: ~₹9,322 crore in FY26 (YoY growth ~18%)

- International revenue: ₹5,177 crore (up 22% YoY)

- Domestic revenue: ₹4,027 crore (up 10% YoY)

- PBILDT margin: 20.0% in FY26 (prev 18.7%)

- PAT: ₹941 crore in FY26

- Net worth: ₹4,977 crore (Mar'26) vs ₹4,642 crore (Mar'25)

- Total debt: ₹1,519 crore (Mar'26) vs ₹1,022 crore (Mar'25)

- Gearing ratio: 0.31x (Mar'26) vs 0.22x (Mar'25)

- Interest coverage: 13.53x (FY26) vs 8.69x (FY25)

- Acquired additional 12.05% stake in Gennova for ~₹232 crore